EFFECTS OF METHYLENE CHLORIDE-SOLUBLE FRACTION OF JAPANESE ANGELICA ROOT EXTRACT, LIGUSTILIDE AND BUTYLIDENEPHTHALIDE, ON PENTOBARBITAL SLEEP IN GROUP-HOUSED AND SOCIALLY ISOLATED MICE
K. Matsumoto et al., EFFECTS OF METHYLENE CHLORIDE-SOLUBLE FRACTION OF JAPANESE ANGELICA ROOT EXTRACT, LIGUSTILIDE AND BUTYLIDENEPHTHALIDE, ON PENTOBARBITAL SLEEP IN GROUP-HOUSED AND SOCIALLY ISOLATED MICE, Life sciences, 62(23), 1998, pp. 2073-2082
Citations number
21
Categorie Soggetti
Biology,"Medicine, Research & Experimental","Pharmacology & Pharmacy
We previously showed that the extract of Japanese angelica root (JAR-E
) reversed the decrease in pentobarbital (PB) sleep induced by isolati
on stress and yohimbine and methoxamine, stimulants of central noradre
nergic systems, in mice. Here, we tested the effects of several fracti
ons from JAR-E and ligustilide and butylidenephthalide, phthalide comp
onents of JAR-E, on PB sleep in isolated mice to elucidate the mechani
sm of the action of JAR-E. Methanol-soluble (Met-S) and -insoluble (Me
t-IS) fractions were obtained from JAR-E. Methylenechloride-soluble (M
C-S) and -insoluble fractions (MC-IS) were prepared from Met-S. MCS (1
1.4-76 mg/kg, p.o.) reversed the isolation stress-induced decrease in
PB sleep, but neither Met-IS (0.8-2.4 g/kg, p.o.) nor MC-IS (0.7-2 g/k
g, p.o.) had the same effect. The i.p. administration of MC-S exhibite
d a similar activity to that observed after the p.o. administration of
the same fraction. Ligustilide (5-20 mg/kg, i.p.) and butylidenephtha
lide (10-30 mg/kg, i.p.) reversed PB sleep decrease in isolated mice.
Both components (20 mg/kg, i.p.) attenuated the suppressive effects of
yohimbine (30 nmol, i.c.v.), methoxamine (200 nmol, i.c.v.) and a ben
zodiazepine inverse agonist FG7142 (10 mg/kg, i.p.) on PB sleep in gro
up-housed mice. These results suggest the contribution of ligustilide
and butylidenephthalide to the effect of JAR-E on PB sleep in isolated
mice, and implicate central noradrenergic and/or GABA, systems in the
effects of these components.